Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Bioventus | 964.42 Mn | 934.96 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 817.51% |
| Mar 28, 2026 | -77.21% |
| Dec 31, 2025 | 332.30% |
| Sep 27, 2025 | -56.79% |
| Jun 28, 2025 | 379.11% |
| Apr 1, 2023 | -218.13% |
| Dec 31, 2022 | 47.62% |
| Oct 1, 2022 | -15,851.07% |
| Jul 2, 2022 | 30.17% |
| Apr 2, 2022 | -1,504.00% |
| Dec 31, 2021 | 98.90% |
| Oct 2, 2021 | 78.95% |
| Jul 3, 2021 | -143.95% |
| Apr 3, 2021 | 989.65% |
| Dec 31, 2020 | -71.74% |
| Sep 26, 2020 | 233.19% |
| Jun 27, 2020 | -157.03% |